991 related articles for article (PubMed ID: 26850516)
1. Concise Review: Heteroplasmic Mitochondrial DNA Mutations and Mitochondrial Diseases: Toward iPSC-Based Disease Modeling, Drug Discovery, and Regenerative Therapeutics.
Hatakeyama H; Goto Y
Stem Cells; 2016 Apr; 34(4):801-8. PubMed ID: 26850516
[TBL] [Abstract][Full Text] [Related]
2. Generation and Characterization of Induced Pluripotent Stem Cells from Patients with mtDNA Mutations.
Hämäläinen RH; Suomalainen A
Methods Mol Biol; 2016; 1353():65-75. PubMed ID: 26187202
[TBL] [Abstract][Full Text] [Related]
3. Induced pluripotent stem cells (iPSCs) for modeling mitochondrial DNA disorders.
Prigione A
Methods Mol Biol; 2015; 1265():349-56. PubMed ID: 25634286
[TBL] [Abstract][Full Text] [Related]
4. Mitochondrial respiratory dysfunction disturbs neuronal and cardiac lineage commitment of human iPSCs.
Yokota M; Hatakeyama H; Ono Y; Kanazawa M; Goto YI
Cell Death Dis; 2017 Jan; 8(1):e2551. PubMed ID: 28079893
[TBL] [Abstract][Full Text] [Related]
5. Mitochondrial respiratory dysfunction caused by a heteroplasmic mitochondrial DNA mutation blocks cellular reprogramming.
Yokota M; Hatakeyama H; Okabe S; Ono Y; Goto Y
Hum Mol Genet; 2015 Aug; 24(16):4698-709. PubMed ID: 26025377
[TBL] [Abstract][Full Text] [Related]
6. Induced pluripotent stem cell-derived models for mtDNA diseases.
Hämäläinen RH
Methods Enzymol; 2014; 547():399-415. PubMed ID: 25416367
[TBL] [Abstract][Full Text] [Related]
7. Gaining Insight into Mitochondrial Genetic Variation and Downstream Pathophysiology: What Can i(PSCs) Do?
Moreira JD; Gopal DM; Kotton DN; Fetterman JL
Genes (Basel); 2021 Oct; 12(11):. PubMed ID: 34828274
[TBL] [Abstract][Full Text] [Related]
8. Metabolic rescue in pluripotent cells from patients with mtDNA disease.
Ma H; Folmes CD; Wu J; Morey R; Mora-Castilla S; Ocampo A; Ma L; Poulton J; Wang X; Ahmed R; Kang E; Lee Y; Hayama T; Li Y; Van Dyken C; Gutierrez NM; Tippner-Hedges R; Koski A; Mitalipov N; Amato P; Wolf DP; Huang T; Terzic A; Laurent LC; Izpisua Belmonte JC; Mitalipov S
Nature; 2015 Aug; 524(7564):234-8. PubMed ID: 26176921
[TBL] [Abstract][Full Text] [Related]
9. Molecular pathomechanisms and cell-type-specific disease phenotypes of MELAS caused by mutant mitochondrial tRNA(Trp).
Hatakeyama H; Katayama A; Komaki H; Nishino I; Goto Y
Acta Neuropathol Commun; 2015 Aug; 3():52. PubMed ID: 26297375
[TBL] [Abstract][Full Text] [Related]
10. TALEN-mediated shift of mitochondrial DNA heteroplasmy in MELAS-iPSCs with m.13513G>A mutation.
Yahata N; Matsumoto Y; Omi M; Yamamoto N; Hata R
Sci Rep; 2017 Nov; 7(1):15557. PubMed ID: 29138463
[TBL] [Abstract][Full Text] [Related]
11. Mitochondrial Transplantation in Mitochondrial Medicine: Current Challenges and Future Perspectives.
D'Amato M; Morra F; Di Meo I; Tiranti V
Int J Mol Sci; 2023 Jan; 24(3):. PubMed ID: 36768312
[TBL] [Abstract][Full Text] [Related]
12. Mitochondrial dynamics and aging: Mitochondrial interaction preventing individuals from expression of respiratory deficiency caused by mutant mtDNA.
Sato A; Nakada K; Hayashi J
Biochim Biophys Acta; 2006; 1763(5-6):473-81. PubMed ID: 16624428
[TBL] [Abstract][Full Text] [Related]
13. The mitochondrial genome in human adaptive radiation and disease: on the road to therapeutics and performance enhancement.
Wallace DC
Gene; 2005 Jul; 354():169-80. PubMed ID: 16024186
[TBL] [Abstract][Full Text] [Related]
14. Concise Review: Induced Pluripotent Stem Cell-Based Drug Discovery for Mitochondrial Disease.
Inak G; Lorenz C; Lisowski P; Zink A; Mlody B; Prigione A
Stem Cells; 2017 Jul; 35(7):1655-1662. PubMed ID: 28544378
[TBL] [Abstract][Full Text] [Related]
15. Genetic Counselling for Maternally Inherited Mitochondrial Disorders.
Poulton J; Finsterer J; Yu-Wai-Man P
Mol Diagn Ther; 2017 Aug; 21(4):419-429. PubMed ID: 28536827
[TBL] [Abstract][Full Text] [Related]
16. Modeling mitochondrial DNA diseases: from base editing to pluripotent stem-cell-derived organoids.
Tolle I; Tiranti V; Prigione A
EMBO Rep; 2023 Apr; 24(4):e55678. PubMed ID: 36876467
[TBL] [Abstract][Full Text] [Related]
17. Techniques and pitfalls in the detection of pathogenic mitochondrial DNA mutations.
Moraes CT; Atencio DP; Oca-Cossio J; Diaz F
J Mol Diagn; 2003 Nov; 5(4):197-208. PubMed ID: 14573777
[TBL] [Abstract][Full Text] [Related]
18. Genetics of Mitochondrial Disease.
Saneto RP
Adv Genet; 2017; 98():63-116. PubMed ID: 28942795
[TBL] [Abstract][Full Text] [Related]
19. Targeted elimination of mutant mitochondrial DNA in MELAS-iPSCs by mitoTALENs.
Yang Y; Wu H; Kang X; Liang Y; Lan T; Li T; Tan T; Peng J; Zhang Q; An G; Liu Y; Yu Q; Ma Z; Lian Y; Soh BS; Chen Q; Liu P; Chen Y; Sun X; Li R; Zhen X; Liu P; Yu Y; Li X; Fan Y
Protein Cell; 2018 Mar; 9(3):283-297. PubMed ID: 29318513
[TBL] [Abstract][Full Text] [Related]
20. Disease-causing mitochondrial heteroplasmy segregated within induced pluripotent stem cell clones derived from a patient with MELAS.
Folmes CD; Martinez-Fernandez A; Perales-Clemente E; Li X; McDonald A; Oglesbee D; Hrstka SC; Perez-Terzic C; Terzic A; Nelson TJ
Stem Cells; 2013 Jul; 31(7):1298-308. PubMed ID: 23553816
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
